Olanzapine versus Haloperidol in the Treatment of Schizophrenia and Other Psychotic Disorders: Quality of Life and Clinical Outcomes of a Randomized Clinical Trial

Background: Little information is available on the impact of the atypical antipsychotic olanzapine on quality of life (QOL). A 6-week, double-blind randomized multicenter trial, with a long-term extension, was conducted to evaluate the clinical efficacy and QOL of olanzapine and haloperidol in treat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Quality of life research 1999-08, Vol.8 (5), p.417-426
Hauptverfasser:	Revicki, Dennis A., Laura A. Genduso, Susan H. Hamilton, Dara Ganoczy, Charles M. Beasley, Jr
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Analysis of Variance Antipsychotic agents Antipsychotic Agents - therapeutic use Benzodiazepines Clinical trials Double-Blind Method Drug therapy Europe Female Haloperidol - therapeutic use Humans Male Mental health outcomes P values Pirenzepine - analogs & derivatives Pirenzepine - therapeutic use Psychometrics Psychoses Psychosis Psychotropic drugs Quality of Life Schizophrenia Schizophrenia - drug therapy Symptoms Wellbeing
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!